Modified Bacteriophage for Tumor Detection and Targeted Therapy

Author:

Shen Yuanzhao123ORCID,Wang Jingyu1,Li Yuting1,Yang Chih-Tsung4ORCID,Zhou Xin123ORCID

Affiliation:

1. College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou 225009, China

2. Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China

3. Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou 225009, China

4. Future Industries Institute, Mawson Lakes Campus, University of South Australia, Adelaide, SA 5095, Australia

Abstract

Malignant tumor is one of the leading causes of death in human beings. In recent years, bacteriophages (phages), a natural bacterial virus, have been genetically engineered for use as a probe for the detection of antigens that are highly expressed in tumor cells and as an anti-tumor reagent. Furthermore, phages can also be chemically modified and assembled with a variety of nanoparticles to form a new organic/inorganic composite, thus extending the application of phages in biological detection and tumor therapeutic. This review summarizes the studies on genetically engineered and chemically modified phages in the diagnosis and targeting therapy of tumors in recent years. We discuss the advantages and limitations of modified phages in practical applications and propose suitable application scenarios based on these modified phages.

Funder

National Natural Science Foundation of China

Publisher

MDPI AG

Subject

General Materials Science,General Chemical Engineering

Reference111 articles.

1. Global Tumor Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Tumors in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. Tumor and Cure: A Critical Analysis;Roy;Indian J. Tumor,2016

3. Hallmarks of cancer: The next generation;Hanahan;Cell,2011

4. Chemotherapy medication errors;Weingart;Lancet Oncol.,2018

5. Chemotherapy: A Double-Edged Sword in Tumor Treatment;Behranvand;Tumor Immunol. Immunother.,2022

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3